云南省寄生虫病防治所
搜 索

OA登录

电子图书

中缅边境西段缅甸恶性疟原虫对氯喹、青蒿琥酯及咯萘啶的敏感性体外测定

时间:2005-05-11

浏览量:2206

 

杨恒林1  廖明铮2  董莹1  杨亚明1

1.云南省疟疾防治研究所(思茅  665000  2.云南省瑞丽市卫生防疫站

全文发表于《中国寄生虫防治杂志》1994年第7卷第14-6

 

提要: 应用Rieckmann体外微量法测得中缅边境西段缅甸境内感染的恶性疟原虫氯喹及我国抗疟新药青蒿琥酯及咯萘啶的抗性率分别为100%、14.3%及19.0%,半数抑制量(ID50)依次为249.54.212.1nmol/L3例抗青蒿琥酯恶性疟原虫对氯喹和咯萘啶的ID50分别为335.6nmol/L43.1nmol/L4例抗咯萘啶恶性疟原虫对氯喹和青蒿琥酯的ID50分别为260.1nmol/L5.0nmolL。结果显示抗青蒿琥酯恶性疟原虫对咯萘啶及氯喹有明显的交叉性;抗咯萘啶恶性疟原虫对青蒿琥酯无交叉抗性。当地恶性疟原虫对氯喹的抗性程度明显高于云南南部恶性疟原虫,但对其它2种药物的敏感性则无明显差别,提示当地恶性疟原虫对青蒿琥酯及咯萘啶无交叉抗性。

关键词:恶性疟原虫,青蒿琥酯,咯萘啶

 

IN VITRO SENSITIVITY OF PLASMODIUM FALCIPARUM IN

CHINA-BURMA BORDER TO CHLOROQUINE, ARTESUNATE AND PYRONARIDINE

Yang Heng-Lin, Liao Ming-Zheng, Dong Ying, Yang Ya-Ming

1.Institute of Malaria prevention and Treatment of Yunnan Province, Simao  665000

2.Ruili City Sannitation and Anti-epidemic Station

 

Abstract: The sensitivity of P. falciparum in the ChinaBurma border to chloroquine (CQ),Artesunate(AT) and pyronaridine(PD) were assayed with in vitro microtechnique during JUN to SPT. of  1991. The resistant rates were 100%(22/22), 14.3%(3/21) and ID50 was 249.5, 4.2 and 12.1 nmol/L respectively. The ID50 of their AT-resistant P.falciparum were 335.6 and 43.1 nmol/L to CQ and PD; The ID50 of 4 P. falciparum against PD were 260.1 and 5.0nmol/L to CQ and AT respectively.

The results suggest that the AT-resistant P. falciparum shows to be evident cross-resistant to PD,but the PD-resistant P. falciparum was not cross-resistant to AT.The P. falciparum has high resistance to CQ,and the resistant degree was higher than the P. falciparum in southern Yunnan of China,but was as sensitive as the later to AT and PD. It indicates that rhe CQ-resistant P. falciparum has no cross-resistance to artesunate and pyronaridine.

Key words:  Plasmodium falciparum, artesunate, pyronaridine

 

:转载请注明出处、谢谢合作

 

联系电话

0879-2122152

云南省普洱市思茅区西园路6号

ADD:6 Xiyuan Road,Puer,Yunnan,P.R.China

版权所有 Copyright © 云南省寄生虫病防治所    滇ICP备05004264号-3 滇公网安备 53080202000356号

技术支持:川海科技

本站部分素材源于网络,如有侵权,请联系作者删除!

健康咨询

合作交流

科研工作

返回顶部